Launches of new medicines in Canada declined consistently in recent years: new data

TORONTO, Ontario – June 13, 2022 – The launches of new medicines in Canada declined consistently and markedly in Canada over the past five years as ongoing changes to the pharmaceutical policy environment, including federal medicine pricing reforms (i.e., PMPRB reforms), have caused uncertainty about the Canadian market.

press releaseGuest UserJune 13, 2022BIOOQuébecNew medicines launches, Canada, IQVIA